Kenji Hashimoto, PhD

Chiba University Center for Forensic Mental Health, Chiba, Japan; Department of Anesthesiology, Pain and Perioperative Medicine, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China; Basic Medicine Research Innovation Center for Cardiometabolic Diseases, Ministry of Education, Southwest Medical University, Luzhou, Sichuan, China

  • 3Articles
  • 8.3KReads
  • 2012–2025Active
  • 9Collaborators
  • 46Citations

About

Kenji Hashimoto, PhD, is affiliated with Chiba University Center for Forensic Mental Health in Japan, the Department of Anesthesiology, Pain and Perioperative Medicine at Zhengzhou University in China, and the Basic Medicine Research Innovation Center for Cardiometabolic Diseases at Southwest Medical University in China. Hashimoto has published extensively on clinical topics including major depressive disorder, posttraumatic stress disorder, and schizophrenia/schizoaffective disorders. His work has addressed treatments such as ketamine and esketamine for treatment-resistant depression, the use of docosahexaenoic acid for PTSD prevention, and the effects of sigma-1 agonists in tardive dyskinesia associated with schizophrenia. His publications span from 2012 to 2025 in Psychiatrist.com journals.

Publications

JCP
Racemic Ketamine vs Esketamine in Treatment-Resistant Depression: The Overlooked Role of Arketamine
Letter to the Editor

Racemic Ketamine vs Esketamine in Treatment-Resistant Depression: The Overlooked Role of Arketamine

October 29, 2025

The authors comment on a recent chart review by Meisner et al.
,
JCP
Original Research

Docosahexaenoic Acid for Selective Prevention of Posttraumatic Stress Disorder Among Severely Injured Patients: A Randomized, Placebo-Controlled Trial

August 26, 2015

, , , et al
PCC
Brief Report

Beneficial Effects of the Sigma-1 Agonist Fluvoxamine for Tardive Dyskinesia in Patients With Postpsychotic Depressive Disorder of Schizophrenia: Report of 5 Cases

November 8, 2012

Tardive dyskinesia (TD) is characterized by involuntary, repetitive, purposeless movements that can affect different parts of the body. Tardive dyskinesia is a well-known side effect of conventional antipsychotics and...
,

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe